Phrenic nerve stimulation
US-2024173074-A1 · May 30, 2024 · US
Swallowable capsule and method for stimulating incretin production within the intestinal tract
US8958879B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8958879-B2 |
| Application number | US-201414273917-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 9, 2014 |
| Priority date | Aug 3, 2009 |
| Publication date | Feb 17, 2015 |
| Grant date | Feb 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for stimulating incretin-producing cells (IP-cells) in the intestinal tract of a patient to secrete an incretin, the method comprising: ingesting a swallowable device configured to travel through the intestinal tract and electrically stimulate the IP-cells at any location in the intestinal tract; delivering an electrical signal from the device to an intestinal wall proximate the device, wherein the signal includes a waveform configured to electric…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61N1/05Primary
Human Necessities · mapped topic
- A61N1/36007Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8958879B2 cover?
- Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particul…
- Who is the assignee on this patent?
- Incube Labs Llc
- What technology area does this patent fall under?
- Primary CPC classification A61N1/05. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).